Board Meeting13 Nov 2026, 06:52 pm
Parmax Pharma Board Meeting Rescheduled to Nov 14
AI Summary
Parmax Pharma Ltd has informed BSE that its Board of Directors meeting, originally scheduled for November 13, 2026, has been postponed to November 14, 2026. The meeting will inter alia consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. Additionally, the board will discuss the shifting of the company's registered office.
Key Highlights
- Board meeting rescheduled to November 14, 2026.
- Unaudited financial results for Q2 FY27 to be approved.
- Shifting of the registered office will be considered.
- Meeting was postponed due to unavoidable circumstances.
Price Impact
More from PARMAX
Quarterly Updates1d ago, 10:20 pm
Parmax Pharma: No Deviation in Utilization of Issue Proceeds for Q2 FY27
Board Meeting1d ago, 9:51 pm
Parmax Pharma Board Approves Shifting Registered Office, Enhancing Borrowing Limits
Auditor1d ago, 9:50 pm
Parmax Pharma Appoints Bakul V. Ganatra & Co as Internal Auditors